Director/PDMR Shareholding
LONDON, U.K AND DALLAS, TX, U.S. – Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, has been notified that on 10 January 2022, Gerald Beaney, a non-executive director, has purchased 13,333 shares of common stock of US$0.001 (“Common Stock”) each in the capital of the Company (“Shares”) at a price of 37.5 pence per Share for a total consideration of £5,000.
As a result, Gerald Beaney’s beneficial interest in the Company is 30,283 shares of Common Stock , representing 0.02% of the total issued share capital.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1 | DETAILS OF THE PERSON DISCHARGING MANAGERIAL RESPONSIBILITIES / PERSON CLOSELY ASSOCIATED | |||
|---|---|---|---|---|
| a) | Name | Gerald Beaney | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Non-executive director | ||
| b) | Initial notification /Amendment | Initial Notification | ||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
| a) | Name | Spectral MD Holdings, Ltd | ||
| b) | LEI | 213800VXW1FVGWTCKL44 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
| a) |
Description of the financial instrument, type of instrument | Shares of common stock of US$0.001 each | ||
| Identification code | USU8457V1099 | |||
| b) | Nature of the transaction | Purchase of Shares | ||
| c) | Price(s) and volume(s) | Price(s)Volume(s)37.5p13,333 |
||
| d) | Aggregated information Volume Price |
13,333 £4,999.88 |
||
| e) | Date of the transaction | 10 January 2022 | ||
| f) |
Place of the transaction | London Stock Exchange |
| Spectral MD Holdings, Ltd. | investors.spectralmd.com |
| Wensheng Fan, Chief Executive Officer | via Walbrook PR |
| Nils Windler, Chief Financial Officer | |
| SP Angel Corporate Finance LLP (NOMAD and Joint Broker) Stuart Gledhill/Caroline Rowe (Corporate Finance)Vadim Alexandre/Rob Rees (Sales & Broking) |
Tel: +44 (0)20 3470 0470 |
| Stifel Nicolaus Europe Limited (Joint Broker) Charles Hoare / Ben Maddison / Nick Harland /Will Palmer-Brown |
Tel: +44 (0)20 7710 7600 |
| Walbrook PR Ltd (Media & Investor Relations) | Tel: +44 (0)20 7933 8780 or spectralMD@walbrookpr.com |
| Paul McManus / Louis Ashe-Jepson Alice Woodings |
Mob: +44 (0)7980 541 893 / +44 (0)7747 515 393 +44 (0)7407 804 654 |